
    
      The investigational product is a medical food and is the result of discoveries following
      extensive research on two preclinical models carried out by a team of researchers at Penn
      State University. This study will utilize the standard "3+3" rule-based dose-escalation
      schemes, which use predetermined dose levels and cohorts of three patients. The total time
      commitment for each subject is approximately three months.
    
  